Also known as: Scorpion Therapeutics
Scorpion Therapeutics is a precision oncology company developing small-molecule therapies to expand the impact of precision medicine for cancer patients. It describes a discovery and development engine integrating genomics, medicinal chemistry, and translational medicine to deliver next-generation oncology programs. The company launched in 2020 in Boston.
Sana Biotechnology named Brian Piper executive vice president and CFO as it advanced SC451 and SG293. The company reported a fourth-quarter loss of $59 million and cash of $138 million.
Sana Biotechnology appointed Brian Piper as Executive Vice President and Chief Financial Officer on February 17, 2026. Piper brings over 25 years of biopharmaceutical financial expertise to the cell and gene therapy company.
